+Search query
-Structure paper
Title | Structural Basis for Inhibition of Mutant EGFR with Lazertinib (YH25448). |
---|---|
Journal, issue, pages | Acs Med. Chem. Lett., Vol. 13, Page 1856-1863, Year 2022 |
Publish date | Apr 2, 2022 (structure data deposition date) |
Authors | Heppner, D.E. / Wittlinger, F. / Beyett, T.S. / Shaurova, T. / Urul, D.A. / Buckley, B. / Pham, C.D. / Schaeffner, I.K. / Yang, B. / Ogboo, B.C. ...Heppner, D.E. / Wittlinger, F. / Beyett, T.S. / Shaurova, T. / Urul, D.A. / Buckley, B. / Pham, C.D. / Schaeffner, I.K. / Yang, B. / Ogboo, B.C. / May, E.W. / Schaefer, E.M. / Eck, M.J. / Laufer, S.A. / Hershberger, P.A. |
External links | Acs Med. Chem. Lett. / PubMed:36518696 |
Methods | X-ray diffraction |
Resolution | 2.4 - 2.6 Å |
Structure data | PDB-7ukv: PDB-7ukw: |
Chemicals | ChemComp-ZRT: ChemComp-HOH: |
Source |
|
Keywords | TRANSFERASE/INHIBITOR / Cancer / Drug Discovery / Kinase / TRANSFERASE / TRANSFERASE-INHIBITOR complex / Drug Design / EGFR / Signal Transduction / Targeted Therapy |